Preclinical studies
Preclinical studies play a pivotal role in assessing the safety and efficacy of new medical interventions before they advance to human trials. These studies need to adhere to regulatory standards to permit use in humans.
Data interpretation
IASON consulting can assist you in drawing meaningful conclusions from complex datasets. Especially in the presence of conflicting or unexpected results, this requires rigorous scientific reasoning.
Ensuring data quality and integrity
Our experts work together with you to ensure that the data collected is of high quality, free from errors, and not subject to manipulation, which is essential for the validity of the study.
Endpoint selection
Careful consideration must be given to ensure endpoints align with the requirements, are preclinically and clinically relevant. We can assist you in selection the most meaningful endpoints for your study.
Study design
A well-crafted study design is pivotal, as it determines the quality of data collected and influences the trial's ability to draw meaningful conclusions.
Population selection
The careful consideration of inclusion and exclusion criteria ensures that the study population accurately reflects the intended patient population, enhancing the generalizability and relevance of the research findings.
Frequently asked questions
Didn't find the answer you were looking for? Connect with us using our Contact form.
-
Molecule classesWe can support you with our expertise across the full spectrum of drug development: from small to large molecules, biologics to oligonucleotides and more.
-
Development stagesTODO
-
Species selectionTODO
-
Technologiese.g. silencing novel approaches?
